GlassScriptPhysician profile
Matthew Michael Brewster
NPI 1699909960
$8,380.20
in general payments reported to CMS, 2019-2025
17 companies · $428 in 2025
The $428 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,095 · 2020: $1,751 · 2021: $2,053 · 2022: $1,345 · 2023: $403 · 2024: $305 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,135.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $2,988.89 | 2019-2020 | |
| Paragon 28, INC. | $2,112.84 | 2019-2025 | Phantom Fibula Nail, Trauma |
| Impactortho, INC. | $1,340.17 | 2022-2023 | |
| Stryker Corporation | $726.54 | 2019-2024 | Prophecy, Mako, Gamma |
| Depuy Synthes Sales INC. | $563.44 | 2019-2025 | Na |
| Treace Medical Concepts, INC. | $178.56 | 2021 | |
| Avanos Medical | $145.87 | 2019 | |
| Fidia Pharma USA INC. | $136.61 | 2019-2021 | |
| Smith+Nephew, INC. | $65.63 | 2020-2021 | |
| Boston Scientific Corporation | $29.02 | 2021 | |
| Osteomed LLC | $16.01 | 2021 | |
| Tenex Health INC. | $15.68 | 2021 | |
| Bioventus LLC | $14.40 | 2021 | |
| Horizon Therapeutics Plc | $11.95 | 2021 | |
| Si-Bone, INC. | $11.83 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $11.59 | 2019 | |
| Pacira Therapeutics, INC. | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Brewster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.